SCHEMBL4484440

SCHEMBL4484440

CCN(NCc1ccc(O)c(OC)c1)C(=O)c1cccc(C(=O)CNCCN2CCC(OC(=O)N(c3ccccc3-c3ccccc3)c3ccccc3-c3ccccc3)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 9/20 0.40
ADRB2 P07550 7/20 0.40
CARM1 Q86X55 1/20 0.36
PRMT6 Q96LA8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494456 0.95 CHRM3 (0.38) CHRM3ADRB2CARM1PRMT6
SCHEMBL4493974 0.94 CHRM3 (0.38) CHRM3ADRB2CARM1PRMT6
SCHEMBL3196137 0.91 CHRM3 (0.49) CHRM3ADRB2
SCHEMBL4474425 0.87 CHRM3 (0.46) CHRM3ADRB2
SCHEMBL3299868 0.85 CHRM3 (0.49) CHRM3ADRB2
SCHEMBL3301257 0.84 CHRM3 (0.52) CHRM3ADRB2
SCHEMBL268484 0.81 CHRM3 (0.53) CHRM3
SCHEMBL714031 0.81 CHRM3 (0.53) CHRM3
SCHEMBL4487280 0.80 CHRM3 (0.47) CHRM3ADRB2
SCHEMBL3175566 0.79 CHRM3 (0.54) CHRM3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632847-B2 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(3-[3-(4-hydroxybenzylamino)propionylamino]benzoylamino)ethyl)piperidin-4-yl ester THERAVANCE, INC. (US) 2009-12-15 US disclosed